Xeris Pharmaceuticals | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
Adcock Ingram Holdings ZAR 1.05B 50.17M 2024-12
Celltrion KRW 276.8B 266.95B 2025-03
Cspc Pharmaceutical CNY 2.1B 22.82M 2024-09
Dianthus Therapeutics USD 6.83M 287K 2024-12
Divis Laboratories Ltd 3.41B 440M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Kangmei Pharma CNY 245.26M 66.07M 2024-09
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 32.57M 26.69M 2024-06
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 7.07M 15.4M 2024-06
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Pacira USD 86.78M 7.16M 2025-03
Perrigo USD 281.2M 46.4M 2025-03
Pharma Mar EUR 13.68M 450K 2025-03
Qiagen NV USD 141.71M 1.05M 2024-12
Sartorius EUR 231.9M 13.6M 2025-03
Sino Biopharmaceutical CNY 5.31B 1.89B 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Tilray USD 72.38M 4.99M 2024-11
Zz Pientze Pharmaceu 171.29M 130.03M 2025-03



Xeris Pharmaceuticals Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.